HHLR Advisors, Ltd. - Net Worth and Insider Trading
HHLR Advisors, Ltd. Net Worth
The estimated net worth of HHLR Advisors, Ltd. is at least $1.9 Billion dollars as of 2025-03-02. HHLR Advisors, Ltd. is the 2102 Investment manager of InnoCare Pharma Ltd and owns about 208,671,222 shares of InnoCare Pharma Ltd (HKSE:09969) stock worth over $1.9 Billion. Details can be seen in HHLR Advisors, Ltd.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that HHLR Advisors, Ltd. has not made any transactions after 2022-09-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of HHLR Advisors, Ltd.
HHLR Advisors, Ltd. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, HHLR Advisors, Ltd. owns 1 companies in total, including InnoCare Pharma Ltd (HKSE:09969) .
Click here to see the complete history of HHLR Advisors, Ltd.’s form 4 insider trades.
Insider Ownership Summary of HHLR Advisors, Ltd.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:09969 | InnoCare Pharma Ltd | 2022-09-21 | 2102 Investment manager |
HHLR Advisors, Ltd. Latest Holdings Summary
HHLR Advisors, Ltd. currently owns a total of 1 stock. HHLR Advisors, Ltd. owns 208,671,222 shares of InnoCare Pharma Ltd (HKSE:09969) as of September 21, 2022, with a value of $1.9 Billion.
Latest Holdings of HHLR Advisors, Ltd.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:09969 | InnoCare Pharma Ltd | 2022-09-21 | 208,671,222 | 9.21 | 1,921,861,955 |
Holding Weightings of HHLR Advisors, Ltd.
HHLR Advisors, Ltd. Form 4 Trading Tracker
According to the SEC Form 4 filings, HHLR Advisors, Ltd. has made a total of 3 transactions in InnoCare Pharma Ltd (HKSE:09969) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in InnoCare Pharma Ltd is the sale of 0 shares on September 21, 2022, which brought HHLR Advisors, Ltd. around $0.
Insider Trading History of HHLR Advisors, Ltd.
- 1
HHLR Advisors, Ltd. Trading Performance
GuruFocus tracks the stock performance after each of HHLR Advisors, Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by HHLR Advisors, Ltd. is -6.7%. GuruFocus also compares HHLR Advisors, Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by HHLR Advisors, Ltd. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how HHLR Advisors, Ltd.'s insider trading performs compared to the benchmark.
Performance of HHLR Advisors, Ltd.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.02 | | | | | |
| Relative Return to S&P 500(%) | -10.68 | | | | | |
HHLR Advisors, Ltd. Ownership Network
Ownership Network List of HHLR Advisors, Ltd.
Ownership Network Relation of HHLR Advisors, Ltd.
HHLR Advisors, Ltd. Owned Company Details
What does InnoCare Pharma Ltd do?
Who are the key executives at InnoCare Pharma Ltd?
HHLR Advisors, Ltd. is the 2102 Investment manager of InnoCare Pharma Ltd. Other key executives at InnoCare Pharma Ltd include 2201 Interest of corporation controlled by you The Goldman Sachs Group, Inc. , Shi Yigong , and Zhao Renbin .
InnoCare Pharma Ltd (HKSE:09969) Insider Trades Summary
Over the past 18 months, HHLR Advisors, Ltd. made no insider transaction in InnoCare Pharma Ltd (HKSE:09969). Other recent insider transactions involving InnoCare Pharma Ltd (HKSE:09969) include a net sale of 259,000 shares made by The Goldman Sachs Group, Inc. , a net sale of 0 shares made by Shi Yigong , and a net sale of 0 shares made by Zhao Renbin .
In summary, during the past 3 months, insiders sold 0 shares of InnoCare Pharma Ltd (HKSE:09969) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 625,000 shares of InnoCare Pharma Ltd (HKSE:09969) were sold and 316,000 shares were bought by its insiders, resulting in a net sale of 309,000 shares.
InnoCare Pharma Ltd (HKSE:09969)'s detailed insider trading history can be found in Insider Trading Tracker table.
InnoCare Pharma Ltd Insider Transactions
HHLR Advisors, Ltd. Mailing Address
Above is the net worth, insider trading, and ownership report for HHLR Advisors, Ltd.. Currently GuruFocus does not have mailing address information for HHLR Advisors, Ltd..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
